Review
Copyright ©The Author(s) 2025.
World J Radiol. Jun 28, 2025; 17(6): 107281
Published online Jun 28, 2025. doi: 10.4329/wjr.v17.i6.107281
Table 1 Comparison of pericoronary adipose tissue measurement parameters
Measurement parameter
Definition/method
Advantages
Limitations
Clinical applications
PCAT thicknessMeasured as the maximum width of proximal pericoronary fat(1) Simple, quick, and highly reproducible; and (2) Suitable for preliminary assessment(1) Provides only 2D information; and (2) Does not reflect PCAT density changesPrimarily used for initial evaluation with limited independent value in clinical decision-making
PCAT volume(1) Attenuation-based segmentation: Calculates voxel volume within the defined range; (2) Manual delineation: Outlines PCAT on axial images; and (3) ROI-based tracing: Manually defines analysis regions along the coronary trajectoryProvides 3D structural information(1) Lack of standardized measurement methods; and (2) Poor comparability across studiesUseful for studying PCAT’s 3D structure, but limited clinical application due to lack of standardization
PCAT densityDirectly measures the mean HU value of PCAT(1) Simple method, applicable to routine CT scans; and (2) Easily standardized with high reproducibility(1) Ignores dynamic changes in PCAT; and (2) Influenced by CT imaging parametersA potential biomarker for inflammation and atherosclerosis, useful for screening high-risk cardiovascular patients
PCAT attenuation/FAIQuantifies pericoronary inflammation by correcting the mean CT attenuation of PCAT(1) Precisely quantifies inflammation; and (2) Highly automated with AI integration(1) Requires specialized software; and (2) Inconsistent across devices, needing standardizationA noninvasive inflammatory biomarker widely used for coronary inflammation detection
PCAT radiomic featuresLeverages AI and deep learning to analyze PCAT texture, morphology, and spatial distribution(1) Provides more detailed lesion characteristics; and (2) Minimizes errors and improves consistency(1) Requires standardized imaging protocols and clinical validation; (2) Complex ROI delineation; and (3) High computational cost requiring specialized softwareHolds great potential in precision medicine for individualized cardiovascular risk prediction and treatment optimization